Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - July 09.10.2026 FJUL.LN IE000YJBT6I5 150,002.00 USD 4,451,911.64 29.679 ...
-
TROOPS, Inc. Announces Landmark Merger with EFFORCE Group, Expanding into Multi-Vertical Digital Asset Infrastructure and Securing Crypto Trading
HONG KONG--(BUSINESS WIRE)--TROOPS (NASDAQ: TROO) announces a merger with EFFORCE Group to expand digital asset infrastructure, crypto trading and sustainability initiatives....
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF 10% - January 09.10.2026 FJAN.LN IE000MDKBOB3 150,002.00 USD 4,476,836.30 29.845 ...
-
Power Integrations and Ideal Power Collaborate on Efficient, Always-On Solid State Circuit Breakers for 800 VDC AI Data Centers
SAN JOSE, Calif.--(BUSINESS WIRE)--Power Integrations (NASDAQ: POWI), the leader in high-voltage integrated circuits for energy-efficient power conversion, and Ideal Power Inc. (NASDAQ: IPWR), developer and provider of its innovative and widely patented B-TRAN® bidirectional semiconductor power switch, today announced a collaboration to deliver a solid-state circuit breaker (SSCB) solution providing fast, efficient, always-on protection that scales with the 800 VDC transition in AI data centers...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - April 09.10.2026 FAPR.LN IE000WX2HZQ7 200,002.00 USD 5,312,427.01 26.562 ...
-
Amphista Therapeutics Announces First Patient Dosed in AMX-883 Phase 1 Clinical Trial for Acute Myeloid Leukemia
CAMBRIDGE, England--(BUSINESS WIRE)--Amphista Therapeutics Limited (‘Amphista’ or ‘the Company’), a leader in the discovery and development of non-cereblon / VHL targeted protein degradation (TPD) medicines, today announced dosing of the first patient in a Phase 1 trial for its lead candidate, AMX-883. Initiated following authorization from the U.S. Food and Drug Administration in June 2026, the BRAMLIE trial will investigate the safety, pharmacokinetics, and preliminary efficacy of AMX-883 mon...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - October 09.10.2026 FOCT.LN IE0004X8KUG5 100,002.00 USD 3,044,179.41 30.441 ...
-
DigitalOcean Launches Agent Learning and Data Services for Recursively Self-Improving AI Agents
SAN FRANCISCO--(BUSINESS WIRE)--Ahead of its Open Intelligence Summit in San Francisco, DigitalOcean (NYSE: DOCN), the AI-Native Cloud, today announced Agent Learning and Data Services as another key element of its modern agentic stack, so teams can launch self-improving agents. Together with Inference Engine and Managed Agents, DigitalOcean is one of the few clouds where agents can run, learn, and improve on one platform. DigitalOcean Agent Learning Services: three products that work as one lo...
-
Farallon Capital Management, L.L.C. UK Regulatory Announcement: Form 8.3
SAN FRANCISCO--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Farallon Capital Management, L.L.C. (on behalf of funds managed jointly with Farallon Capital Europe LLP and Farallon Partners, L.L.C.) (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming...
-
Americhem在中国苏州启用全新洁净配混设施
中国苏州--(BUSINESS WIRE)--(美国商业资讯)-- 全球定制聚合物解决方案领导者Americhem于9月28日举行了其位于苏州的全新洁净配混设施启用仪式。此项投资进一步提升了Americhem服务中国、亚太地区以及在该区域开展生产制造业务的全球客户的能力。 该设施专为满足严苛医疗器械应用所需的ISO 13485和cGMP要求而设计,在Americhem美国和丹麦现有认证能力基础上,进一步扩展了其全球洁净配混网络。该设施使可靠的生产能力、稳定一致的产品质量以及专业技术支持更加贴近医疗健康OEM客户,助力其开发和制造受严格监管的产品。 “苏州设施的扩建进一步增强了我们服务全球客户的能力,同时将Americhem的技术专长和制造能力带到亚太地区客户身边,” Americhem首席执行官(CEO)John Richard表示。“这项投资体现了我们对全球供应连续性、区域响应能力以及医疗健康客户所依赖的高质量标准的坚定承诺。” “我们的客户需要的不仅仅是本地化生产能力。他们更需要一位能够理解其技术要求、质量期望和增长目标的材料解决方案合作伙伴,” Americhem亚太区副总裁 R...